169 related articles for article (PubMed ID: 37034342)
1. Cardiomyocyte-specific deletion of TLR4 attenuates angiotensin II-induced hypertension and cardiac remodeling.
Theobald D; Nair AR; Sriramula S; Francis J
Front Cardiovasc Med; 2023; 10():1074700. PubMed ID: 37034342
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
Matsuda S; Umemoto S; Yoshimura K; Itoh S; Murata T; Fukai T; Matsuzaki M
J Atheroscler Thromb; 2015 Aug; 22(8):833-44. PubMed ID: 25752363
[TBL] [Abstract][Full Text] [Related]
4. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
5. Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.
González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liu Y; Leung P; Dai X; Yang XP; Peterson EL; Carretero OA
J Hypertens; 2015 Jan; 33(1):144-52. PubMed ID: 25304471
[TBL] [Abstract][Full Text] [Related]
6. Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension.
Dange RB; Agarwal D; Masson GS; Vila J; Wilson B; Nair A; Francis J
Cardiovasc Res; 2014 Jul; 103(1):17-27. PubMed ID: 24667851
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension.
Sriramula S; Cardinale JP; Francis J
PLoS One; 2013; 8(5):e63847. PubMed ID: 23691105
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 signaling deficiency in cardiac cells ameliorates Ang II-induced cardiac inflammation and remodeling.
Ye S; Lin K; Wu G; Xu MJ; Shan P; Huang W; Wang Y; Liang G
Transl Res; 2021 Jul; 233():62-76. PubMed ID: 33652137
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Okuno K; Torimoto K; Cicalese SM; Preston K; Rizzo V; Hashimoto T; Coffman TM; Sparks MA; Eguchi S
Hypertension; 2023 Mar; 80(3):668-677. PubMed ID: 36628961
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
Sriramula S; Francis J
PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
Di Zhang A; Nguyen Dinh Cat A; Soukaseum C; Escoubet B; Cherfa A; Messaoudi S; Delcayre C; Samuel JL; Jaisser F
Hypertension; 2008 Dec; 52(6):1060-7. PubMed ID: 18981328
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
17. Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors.
Cheng Z; Zhang M; Hu J; Lin J; Feng X; Wang S; Wang T; Gao E; Wang H; Sun D
J Mol Cell Cardiol; 2018 Dec; 125():117-128. PubMed ID: 30193956
[TBL] [Abstract][Full Text] [Related]
18. Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling.
Izumiya Y; Araki S; Usuku H; Rokutanda T; Hanatani S; Ogawa H
Int J Vasc Med; 2012; 2012():246058. PubMed ID: 22848833
[TBL] [Abstract][Full Text] [Related]
19. Oleic Acid Attenuates Ang II (Angiotensin II)-Induced Cardiac Remodeling by Inhibiting FGF23 (Fibroblast Growth Factor 23) Expression in Mice.
Liu T; Wen H; Li H; Xu H; Xiao N; Liu R; Chen L; Sun Y; Song L; Bai C; Ge J; Zhang Y; Chen J
Hypertension; 2020 Mar; 75(3):680-692. PubMed ID: 31928110
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.
Brown SM; Smith CE; Meuth AI; Khan M; Aroor AR; Cleeton HM; Meininger GA; Sowers JR; DeMarco VG; Chandrasekar B; Nistala R; Bender SB
Endocrinology; 2017 Oct; 158(10):3592-3604. PubMed ID: 28977602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
